CEPH Message Board - Msg: 987203

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: KurtVedder who wrote (64)	3/14/1997 6:27:00 AM
From: harkenman	of 998

First Call predicts consensus earnings of $-2.82 for 1997 with 8 : 1 brokers revising earnings downwards!. I will publish a table with the latest earnings estimates as well as the buy:hold:sell ratings as compiled by First Call. I couldn't find the 11/8/96 Value LIne report you quote but the Special Situation report Value Line Section 3 09/20/96 report isn't as rosey as you may try to hype. The latest Value Line Feb 7, 1997 report predicts earnings of -$1.5 for 1997 and gives it a 4 in safety. Is your report from an outdated issue superseded by the February report? Can you print it? By the way the downturns for CEPH stock were all due to delays of filing the Myotrophin NDA and the negative reports published from the Phase III studies, a requirement by SEC regulations. Your long stategy is excellent by buying in the lows but this is a very risky stock. Regeneron was hovering in the $18 range and today it is in the less than $9.00 Category. I wish you luck but the odds are againts it. Even the 9 brokers who follow it have done downwards estimates in earnings!!!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next